Inflam Cancer Research Results
Inflam, inflammation: Click to Expand ⟱
| Source: |
| Type: |
Cancer and inflammation are closely linked, with chronic inflammation contributing to the development and progression of cancer. Various inflammatory mediators and cells are involved in this process.
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, *antiOx↑, *cardioP↑, *neuroP↑, TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, CDC2↓, AMPK↝, mTOR↝, Casp8↑, Casp9↑, Cyt‑c↑, TumCMig↓, TumCI↓, EMT↓, MMPs↓, E-cadherin↓, Telomerase↓, *toxicity↓, GRP78/BiP↓, EGFR↓, CDK4↓, COX2↓, PGE2↓, p‑JAK2↓, p‑STAT3↓, MMP2↓, MMP9↓, GutMicro↑, eff↝, *BioAv↓, BioAv↑,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
LoVo |
|
|
|
TumVol↓, Ki-67↓, COX2↓, AMPK↑, mTOR↓, NF-kB↓, cycD1/CCND1↓, survivin↓, P53↑, cl‑Casp3↑, TumCP↓, Inflam↓, COX2↓, ACC↑,
Risk↓, TumMeta↓, Apoptosis↑, COX2↓, iNOS↓, IL1β↓, IL6↓, IL10↓, P53↑, P21↓, survivin↓, chemoPv↑, *Inflam↓,
GutMicro↑, HCAR2↑, AntiCan↑, Inflam↓, IL18↑,
Risk↓, P53↑, MDM2↓, COX2↓, Wnt↓, NF-kB↓, CDK2↓, CDK4↓, p‑RB1↓, cycE/CCNE↓, P21↑, NRF2↓, ROS↑, Casp8↑, Fas↑, TRAIL↑, DR5↑, MMP↓, Cyt‑c↑, selectivity↑, P450↝, GSTs↝, RadioS↑, Inflam↓, β-catenin/ZEB1↓, EGFR↓, TumCCA↑, ChemoSen↑,
OS↑, Inflam↓, TumCG↓, STAT3↓, NF-kB↓, β-catenin/ZEB1↓, Slug↓, XIAP↓, CDK4↓, cycD1/CCND1↓, Bcl-2↓,
CSCs↓, TumCG↓, Inflam↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
DLD1 |
|
|
|
β-catenin/ZEB1↓, Wnt↓, TumCP↓, TumCMig↓, *antiOx↑, *Inflam↓, *hepatoP↑, *neuroP↑, *Bacteria↓, *memory↑, AntiCan↑, NF-kB↓, cFos↓, ATF2↓, CREB↓,
Inflam↓, AntiCan↑, Apoptosis↑, MMP↓, P53↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, NF-kB↓, IL6↓, IL1β↓, *antiOx↑, *lipid-P↓, *ROS↓, MAPK↓, JAK↓, STAT↓, PI3K↓, Akt↓, chemoP↑, ROS⇅, DNAdam↑, ChemoSen↝,
NF-kB↓, FAK↓, Ki-67↓, MMP9↓, CSCs↓, CD44↓, CD133↓, ALDH1A1↓, EMT↓, ChemoSen↑, Hif1a↓, ITGB1↓, Inflam↓,
| - |
in-vitro, |
CRC, |
HCT8 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
LS174T |
|
|
|
GlucoseCon↓, lactateProd↓, Hif1a↓, Inflam↓, miR-155↓, STAT3↓, Glycolysis↓, IL6↓, Warburg↓,
xCT↓, Inflam↓, Apoptosis↓, GSH↓, ROS↑, TumCG↓, selectivity↑, eff↑, eff↓,
eff↑, TumCCA↑, Inflam↓, COX2↓, iNOS↓, P53↑, P21↑, cl‑Casp3↑,
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
Showing Research Papers: 1 to 14 of 14
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 14
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSH↓, 1, GSTs↝, 1, NRF2↓, 1, ROS↑, 2, ROS⇅, 2, xCT↓, 1,
Mitochondria & Bioenergetics ⓘ
CDC2↓, 1, MMP↓, 2, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
ACC↑, 1, AMPK↑, 1, AMPK↝, 1, cMyc↓, 1, CREB↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 2, Apoptosis↓, 1, Apoptosis↑, 3, ATF2↓, 1, BAX↑, 2, Bcl-2↓, 2, Bcl-2↑, 1, Casp3↑, 2, cl‑Casp3↑, 2, Casp7↑, 1, Casp8↑, 2, Casp9↑, 3, Cyt‑c↑, 2, DR5↑, 1, Fas↑, 1, iNOS↓, 2, JNK↑, 1, MAPK↓, 1, MDM2↓, 1, p27↑, 1, p38↑, 1, survivin↓, 3, Telomerase↓, 1, TRAIL↑, 1,
Kinase & Signal Transduction ⓘ
HCAR2↑, 1,
Protein Folding & ER Stress ⓘ
GRP78/BiP↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 5, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 3, cycD1/CCND1↓, 4, cycE/CCNE↓, 2, P21↓, 1, P21↑, 3, p‑RB1↓, 1, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
ALDH1A1↓, 1, CD133↓, 1, CD44↓, 1, cFos↓, 1, CSCs↓, 2, EMT↓, 3, ERK↓, 1, GSK‐3β↓, 1, mTOR↓, 2, mTOR↝, 1, PI3K↓, 2, PTEN↑, 1, STAT↓, 1, STAT3↓, 3, p‑STAT3↓, 1, TumCG↓, 3, Wnt↓, 2,
Migration ⓘ
E-cadherin↓, 2, FAK↓, 1, ITGB1↓, 1, Ki-67↓, 2, miR-155↓, 1, MMP2↓, 1, MMP9↓, 2, MMPs↓, 2, Slug↓, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 3, TumMeta↓, 2, Twist↓, 1, β-catenin/ZEB1↓, 4,
Angiogenesis & Vasculature ⓘ
angioG↑, 1, EGFR↓, 2, Hif1a↓, 2, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 6, HCAR2↑, 1, IL10↓, 1, IL18↑, 1, IL1β↓, 2, IL6↓, 3, Inflam↓, 10, JAK↓, 1, p‑JAK2↓, 1, NF-kB↓, 6, p‑NF-kB↑, 1, PGE2↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 3, ChemoSen↝, 1, eff↓, 1, eff↑, 2, eff↝, 1, P450↝, 1, RadioS↑, 1, selectivity↑, 3,
Clinical Biomarkers ⓘ
EGFR↓, 2, GutMicro↑, 2, IL6↓, 3, Ki-67↓, 2,
Functional Outcomes ⓘ
AntiCan↑, 3, chemoP↑, 2, chemoPv↑, 1, OS↑, 1, Risk↓, 2, TumVol↓, 1,
Total Targets: 122
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 4, Catalase↑, 1, GPx↑, 1, GSTA1↑, 1, lipid-P↓, 1, ROS↓, 1, SOD↑, 1,
Migration ⓘ
MMP13↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL1β↓, 1, Inflam↓, 4, PGE2↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↝, 1, Half-Life↝, 1,
Functional Outcomes ⓘ
cardioP↑, 1, hepatoP↑, 2, memory↑, 1, neuroP↑, 2, toxicity↓, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 21
Scientific Paper Hit Count for: Inflam, inflammation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:953 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page